By LLuvia Mares
New York, Oct. 24 - Optimer Pharmaceuticals, Inc. announced today it plans to raise a $35.9 million private placement of common stock.
The company will sell 4.6 million shares of stock at $7.80 per share. No warrants will be issued in the transaction.
The deal is expected to close on Oct. 29.
Piper Jaffray & Co. is the placement agent in the offering.
Proceeds will be used toward the company's phase 3 clinical trials.
San Diego-based Optimer Pharmaceuticals is a biopharmaceutical company specializing on the discovering, developing and commercializing of innovative treatments.
| Issuer: | Optimer Pharmaceuticals, Inc.
|
| Issue: | Stock
|
| Amount: | $35.9 million
|
| Shares: | 4.6 million
|
| Price: | $7.80 per share
|
| Warrants: | No
|
| Placement agent: | Piper Jaffray & Co.
|
| Announcement date: | Oct. 23
|
| Settlement date: | Oct. 29
|
| Stock symbol: | Nasdaq: OPTR
|
| Stock price: | $8.37 at last close Oct. 23
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
